Management of miscarriage in general practice
C M Yan 忻財敏
HK Pract 2003;25:367-372
Summary
Miscarriage is a common complication in early pregnancy. It is mostly idiopathic
and the prognosis is usually good. The initial management may be provided by family
physicians who, therefore, should have up-to-date knowledge of its management. Apart
from the clinical management by history taking, physical examination and investigation,
counselling and psychological support are also important in the care of patients
suffering from miscarriage. The idea of pre-conception care is useful for women
who are preparing for subsequent pregnancies after a miscarriage. In addition, referral
to "early pregnancy assessment unit" by specialist is advisable in the next pregnancy.
摘要
在懷孕的初期,流產十分常見。流產的原因大多不明,但一般而言,是不會影響未來的孕娠。 家庭醫生應對流產的處理有正確的認識,以能為流產病人提供初步的處理。 除了臨床的檢查和化驗,適當的輔導和心理支持也同樣重要。
流產後及在再度懷孕之前,婦女應有充足的孕前準備。還有, 再度懷孕後,更應盡早到「早期懷孕評估診所」作檢驗。
Introduction
Miscarriage is common. The overall rate is thought to be 50%.1 Clinically
recognised pregnancy loss is estimated to be 12-15%.2 Management of miscarriage
is commonly encountered by obstetricians and is not a rare scenario in the daily
practice of the family physicians. A study from the United Kingdom reported that
most miscarriage first presenting to family physicians would eventually be managed
in hospital3 or in an early pregnancy assessment unit (EPAU). A wide
spectrum of patterns of management were noted. But how many are evidence-based?
Another study showed that women suffering from miscarriage were dissatisfied with
the medical care provided by their family physicians.4
Miscarriage is conventionally treated by surgical evacuation of the uterus, but
medical evacuation is now possible. Moreover, there is still a place for the expectant
management which allows the spontaneous expulsion of the products of gestation.
The modern-day family physician should be aware of these.
Definitions
The definition varies in different places. In Hong Kong, miscarriage is the spontaneous
termination of a pregnancy or early loss of foetal tissue from the uterus before
28 completed weeks of pregnancy. Most are early, well before 12 weeks. Nowadays,
"miscarriage" replaces "abortion" since the latter may imply termination of unwanted
pregnancy. Missed abortion is referred to as silent or delayed miscarriage while
incomplete and complete abortion is called incomplete and complete miscarriage respectively.
In Chinese, there is no problem in differentiating miscarriage (流產,小產)
and termination of pregnancy (人工流產,墮胎).
First trimester miscarriage happens before the twelve week of gestation while second
trimester miscarriage are those between twelve and twenty-eight weeks. Second trimester
miscarriage is much less common than the first trimester - sporadic second trimester
miscarriages occur in less than 5% of all pregnancy losses. Recurrent miscarriage
(RM), previously called habitual abortion, is defined as the occurrence of three
or more consecutive miscarriages.
Aetiology
Though miscarriages are categorised into first and second trimester, overlaps in
their aetiology exist.
The first trimester sporadic miscarriage is mostly idiopathic. Abnormal foetal chromosomal
makeup is detected in at least 50% of these miscarriages (compared with 20% in the
second trimester).5 Investigation is not warranted unless the miscarriage
is recurrent.
Since the incidence of spontaneous clinical pregnancy loss is about 15%, the calculated
chance of RM should be about 0.34%. However, RM affects 1% of women. The discrepancy
implies there are underlying causes in some cases of RM. About half of RM are idiopathic.
The other causes include parental chromosomal abnormalities, antiphospholipid syndrome
(APS), hormonal causes associated with oligomenorrhoea and structural anomalies
such as uterine malformation and cervical incompetence. "Luteal phase defect" is
defined as a defective corpus luteum with insufficient progesterone production.
This concept of luteal phase defect is contentious because there is still no consensus
as to how it should be diagnosed and whether treatment will improve pregnancy outcome.
However, serum progesterone levels are not predictive of pregnancy outcome and there
is no evidence to support the use of exogenous progesterone supplementation in early
pregnancy.6,7 Currently, the focus is on thrombophilias, such as activated
protein C resistance which is detected in a small number of women with RM. More
evidence is awaited to establish its role.
The aetiology of second trimester miscarriage include idiopathic causes, anti-phospholipid
syndrome (APS), structural uterine anomalies, cervical incompetence and bacterial
vaginosis.
Diagnosis
The diagnosis is usually made by ultrasonogram. Silent miscarriage is diagnosed
if the gestational sac has a mean diameter greater than 20mm without evidence of
an embryo or yolk sac, or if the embryo has a crown rump length greater than 6mm
without evidence of foetal heart pulsations.8 Transvaginal ultrasonogram
should always be employed if any doubt exists on transabdominal scanning.
The distinction between incomplete and complete miscarriage relies on a combination
of ultrasonographic and clinical features. It is difficult to make a diagnosis based
on the morphology and thickness of the endometrial lining. Thick and heteroechogenic
endometrial lining in a patient who is having heavy vaginal bleeding usually implies
incomplete miscarriage while thin and uniform endometrial lining in whom who has
little vaginal bleeding suggests complete miscarriage.
Management of miscarriage
Management starts with history and physical examination (Table 1).
Ectopic pregnancy should always be considered as a differential diagnosis of miscarriage.
History should include the date of last menstrual period, the usual menstrual cycle,
method of contraception, date of pregnancy test(s) done, the details about vaginal
bleeding and abdominal pain. The presence of shoulder tip pain may point to diaphragmatic
irritation from intra-peritoneal bleeding in ectopic pregnancy. Physical examination
may reveal pallor when there is severe vaginal or intra-abdominal bleeding. Pulse
and blood pressure must be taken. The abdominal examination in miscarriage is usually
unremarkable except when there is ruptured ectopic pregnancy which may give rise
to guarding and rebound tenderness. On pelvic examination, a dilated cervical os
suggests incomplete or inevitable miscarriage. Foetal tissue mass may be seen. Cervical
excitation tenderness may be demonstrated with ectopic pregnancy. A bimanual examination
should be done to assess the size of the uterus. Tenderness and mass in the adnexal
region may be a feature of ectopic pregnancy.
Table 1: Management of miscarriage
|
History
|
|
Menstrual history and last menstrual period
|
|
Date of pregnancy test(s)
|
|
Details of vaginal bleeding and abdominal pain
|
|
Other symptoms, e.g. shoulder tip pain
|
|
|
Physical examination
|
|
General
|
|
-
|
pallor, blood pressure and pulse
|
|
Abdominal
|
|
-
|
guarding, tenderness, rebound tenderness
|
|
Pelvic
|
|
-
|
cervical os status and cervical excitation tenderness, bimanual uterine size assessment,
and adnexal mass and tenderness
|
|
|
|
Investigations
|
|
Urine pregnancy test
|
|
Serum human chorionic gonadotrophin level
|
|
Pelvic ultrasonogram
|
|
Complete blood count
|
|
Blood group and Rhesus status
|
|
|
Counselling and support
|
|
Pelvic ultrasonogram is essential. A threatened miscarriage is diagnosed when the
cervical os is closed and the ultrasonogram demonstrates a viable pregnancy. Retained
tissues will be demonstrated inside the uterus in incomplete miscarriage. Inevitable
miscarriage is diagnosed when the internal cervical os is dilated, usually preceded
by vaginal bleeding and lower abdominal pain. If the uterus is empty, the differential
diagnoses will include complete miscarriage, ectopic pregnancy or very early intrauterine
pregnancy. A further scan should be performed one week later.
The urine pregnancy test is positive in miscarriage and ectopic pregnancy. Sometimes,
serum human chorionic gonadotrophin level may need to be checked. Ectopic pregnancy
must be ruled out if the serum human chorionic gonadotrophin level is higher than
2000iu/l, and the intrauterine gestational sac is not visible in the transvaginal
pelvic ultrasonogram.9
A complete blood count is taken to detect anaemia in a patient who is bleeding vaginally.
Rhesus status should also be ascertained if not yet known. Anti-D should be given
to those non-immunised Rh negative women except where the foetus is viable and less
than 12 weeks gestation.10
Options of treatment of non-viable pregnancy
Threatened miscarriage is diagnosed if foetal viability is demonstrated. Septic
miscarriage and heavy vaginal bleeding, will require urgent surgical evacuation
of the uterus, otherwise three options are now available. They are expectant, medical
and surgical management for non-viable pregnancy (silent and incomplete miscarriage).
Expectant management for incomplete miscarriage is effective in about 80% where
the endometrial lining is 15-50mm thick.11 It is less effective for silent
miscarriage where about half of the patients may eventually require or request more
active treatment.12 However, the patients have to wait for up to 4 weeks
before the miscarriage is complete. Therefore, most of them still wish to have surgical
evacuation of the uterus, which is 94% effective, but has a 8% risk of developing
complications such as infection, uterine perforation and cervical laceration.13
Medical management is recently explored as an alternative. There were studies on
the effectiveness of prostaglandins with or without mifepristone. It is difficult
to conclude which regimen is better because there are non-uniformities in the selection
criteria, choice and dosage of medication, and the definition of success. The success
rate quoted was 61-92%.14-16 A commonly adopted regimen is 400mcg vaginal
misoprostol, a prostaglandin E1 analogue. Caution should be exercised if the women
have allergy to prostaglandins, cerebrovascular disease, coronary artery disease,
hypotension or hypertension. Second trimester miscarriages are, in general, managed
by medical method using similar misoprostol regimen since surgical treatment is
more complicated in the second trimester. Expectant management is also an alternative
(Table 2). However, one should be aware of the risk of coagulopathy
with prolonged retention of non-viable foetal tissues for more than 4 weeks in late
second trimester.
After a sporadic first trimester miscarriage, further investigations are generally
not indicated. Investigations are suggested for RM as follows: parental karyotypes,
antiphospholipid antibodies and pelvic ultrasonogram (Table 3).
For second trimester miscarriage, the following tests may be performed: antiphospholipid
antibodies, pelvic ultrasonogram, hysteroscopy and cervical competence test, and
vaginal and cervical swabs (Table 4).
Counselling and support
Counselling and psychological support is important to patients with miscarriage.
Research has shown that psychological distress is reduced by appropriate counselling
and support.17 The grief in miscarriage is comparable to that after stillbirth
or the death of a relative. Miscarriage is increasingly being viewed as "perinatal
bereavement".18 Moreover, the grief is a hidden one - others may never
know the sufferer has been pregnant. Bereavement is particularly difficult because
there is no visible child to mourn,19 no memories or shared life experiences20
and there is a lack of recognition of the significance of such loss by society.21,22
The suppression of appropriate mourning due to society's inhibition may cause further
stress and life-long emotional consequences. Fears may also originate from concern
about future fertility and surgery. The experience of miscarriage may also be a
physically traumatic event involving pain, blood loss, hospitalisation and an operation.
Hence, proper counselling and support from professionals are important.
The knowledge of pregnant women about miscarriage was poor and there were a lot
of misconceptions.23 Those misconceptions will add to the emotional disturbance.
An information pamphlet on this topic for distribution to every patient with miscarriage
is deemed to be useful.
Prognosis and prevention
The prognosis is related to the cause. In most cases where no cause is found, the
prognosis is usually favourable, though it decreases with increasing maternal age
and number of previous miscarriages.24 In RM, the prognosis is not affected
by whether the RM is primary (no previous successful pregnancy) or secondary (previous
successful pregnancies).25
Management is according to the cause. However these treatments are not evidence-based.
At the moment, women with RM and APS are recommended to use low-dose aspirin 75mg
daily throughout pregnancy. So far, the number of women in the treatment trials
is small and there is continuing controversy about the value of heparin in addition
to low-dose aspirin. Unless there is a history of maternal thrombosis, antenatal
heparin is not routinely recommended.26 A randomised prospective study
suggested that human chorionic gonadotrophin (HCG) therapy improved pregnancy outcome
only in women with oligomenorrhoea and RM.27 Further extension of the
study confirmed that those who did not receive HCG have a consistently poorer chance
of success (59%) than women treated with HCG, who have a 75% chance of success.28
It is difficult to diagnose cervical incompetence objectively. The diagnosis is
usually based on a history of recurrent second trimester miscarriages and an abnormal
cervical competence test such as the retrograde cervical dilatation. A meta-analysis
suggests a trend toward cervical cerclage reducing foetal losses before 34 weeks
of gestation. It can be interpreted that 20 cervical cerclages are needed to prevent
one case of miscarriage or preterm birth less than 34 weeks of gestation.29
For the majority with idiopathic cause, tender loving care is proven to be effective
in the management of RM with a success rate of 86%.30
Pre-conception care
Women are eager to know how to prepare for subsequent pregnancies. Though there
are no specific strategies, something can be done before the next pregnancy is attempted.
When a woman is seen for miscarriage, it is a good time to introduce the concept
of pre-conception care.31 The past health, drug history, family history
and social history are reviewed and screening tests are carried out to detect her
reproductive risks. Susceptibility to Rubella infection may be discovered even with
a history of prior vaccination. Rubella antibody levels may drop with time and so
it is probably advisable to check antibody status before each pregnancy. Pregnancy
should be avoided for one month after vaccination. At present, there is no evidence
to support the use of vitamins or trace elements when planning a pregnancy except
for folic acid, which can reduce the incidence of neural defect-affected pregnancies.
It is recommended that women should take folic acid 400mcg daily from the time they
decide to become pregnant till the twelfth week of gestation.32 There
is much evidence that cigarette smoking has harmful effects on foetus and smoking
remains one of the few potentially preventable factors associated with low birthweight
and perinatal death. In those who cannot stop smoking, reduction should be the goal
for all prospective mothers (Table 5).
Table 5: Pre-conception care
|
History
|
|
Age and occupation
|
|
Family history
|
|
Gynaecological and obstetric history
|
|
Past health and drug history
|
|
Social history
|
|
|
Physical examination
|
|
General examination
|
|
Pelvic examination and Pap smear
|
|
|
Screening tests
|
|
Mean corpuscular volume
|
|
Rubella immunity
|
|
Hepatitis B carrier status
|
|
Sexually transmitted disease screening (if indicated)
|
|
|
Health promotion advice
|
|
Folic acid 400mcg daily
|
|
Balanced diet and moderate exercise
|
|
No more than one standard drink of alcohol per day
|
|
Quit, or at least, reduce smoking
|
|
Management of subsequent pregnancy
Family physicians should refer the women to a specialist or an EPAU early so that
weekly ultrasonogram is done to provide assurance. The concept of gestational milestones
as suggested by Farquharson is useful: the most perilous gestation for pregnant
women with idiopathic RM is between 6 and 8 weeks and beyond 10 weeks the miscarriage
rate is only 0.6%.33 Moreover, once the foetal heart activity is detectable,
the anticipated pregnancy loss is 3%.34 In some centres, 2-weekly serum
human chorionic gonadotrophin level is performed. A doubling time of 2 days or less
is consistent with normal pregnancy.
Relaxation exercise is also useful for the inevitably nervous sufferers of RM in
the subsequent pregnancies.35 Of course, tender loving care and support
from the staff in the EPAU is important (Table 6).
Conclusion
Miscarriage is a common condition that family physicians should be prepared to manage.
Management should be evidence-based and empirical treatments should be avoided because
they may be unnecessary and even potentially harmful. Education and counselling
are important in the holistic care for women with miscarriage. After the initial
management provided by family physicians, referral for further management by gynaecologists
is sometimes needed. Women should be introduced to the concept of pre-conception
care.
Key messages
- Miscarriage is common. The aetiology of sporadic first trimester miscarriage is
mostly idiopathic and the prognosis is usually favourable.
- Pelvic ultrasonogram is pivotal in the diagnosis of miscarriage, and transvaginal
route should be used if doubts exist with transabdominal one.
- Rhesus status should be ascertained and anti-D should be given to non-immunised
Rh negative women except where the foetus is viable and less than 12 weeks gestation.
- Surgical, medical and expectant treatments are available as options for non-viable
pregnancy.
- Counselling and psychological support is as important as clinical treatment in the
holistic management. The concept of pre-conception care should also be introduced.
- Early referral to the specialist or an early pregnancy assessment unit is suggested
for subsequent pregnancies.
C M Yan, MRCOG, FHKAM(O&G)
Senior Medical Officer,
Department of Obstetrics and Gynaecology, United Christian Hospital.
Correspondence to : Dr C M Yan, Department of Obstetrics and Gynaecology,
United Christian Hospital, Kwun Tong, Kowloon, Hong Kong.
References
- Wilcox AJ, Weinberg CR, O'Conner JF, et al. Incidence of early loss of pregnancy.
N Eng J Med 1988;319:189-194.
- Hertz-Piccioto I, Samuels SJ. Incidence of early loss of pregnancy. N Eng J Med
1988;319:1483-1484.
- Everett C, Ashurst H, Chalmers I. Reported management of threatened miscarriage
by general practitioners in Wessex. Br Med J 1987;295:583-586.
- Friedman T. Women's experiences of general practitioner management of miscarriage.
J Royal College Gen Practitioners 1989;39:456-458.
- Olsen SB, Magenis RE. Cytogenetic aspects of recurrent pregnancy loss. Seminars
in Reprod Endocrinology 1988;6:191-202.
- Ogasawara M, Kajiura S, Katano K, et al. Are serum progesterone levels predictive
of recurrent miscarriage in future pregnancies? Fertil Steril 1997;68:806-809.
- Goldstein P, Berrier J, Rosen S, et al. A meta-analysis of randomised control trials
of progestational agents in pregnancy. Br J Obstet Gynaecol 1989;96:265-274.
- Royal College of Radiologists, Royal College of Obstetricians and Gynaecologists.
Guidance on ultrasound procedures in early pregnancy. 1995.
- Stovall TG, Ling FW. Ectopic pregnancy. Diagnostic and therapeutic algorithms minimising
surgical intervention. J Reprod Med 1993;38:807-812.
- Royal College of Obstetricians and Gynaecologists. The management of early pregnancy
loss. RCOG Guideline 2000.
- Gronlund L, Gronlund A-L, Clevin L, et al. Spontaneous abortion: expectant management,
medical treatment or surgical evacuation. Acta Obstet Gynaecol Scandinavica 2002;81:781-782.
- Shillito J, Walker JJ. Early pregnancy assessment units. In: Farquharson RG (ed).
Miscarriage. Salisbury: Quay Publishing; 2002;p139-140.
- Chung TKH, Lee DTS, Cheung LP, et al. spontaneous abortion: a randomised controlled
trial comparing surgical evacuation with conservative management using misoprostol.
Fertil Steril 1999;71:1054-1059.
- Pang MW, Lee TS, Chung TK. Incomplete miscarriage: a randomised controlled trial
comparing oral with vaginal misoprostol for medical evacuation. Hum Reprod 2001;16:2283-2287.
- Tang OS, Ho PC. Pilot study on the use of sublingual misoprostol for medical abortion.
Contraception 2001;64:315-317.
- Ngai SW, Chan YM, Tang OS, et al. Vaginal misoprostol as medical treatment for first
trimester spontaneous miscarriage. Hum Reprod 2001;16:1493-1496.
- Turner MJ, Flannelly GM, Wingfield M, et al. The miscarriage clinic - an audit of
the first year. Br J Obstet Gynaecol 1991;98:306-308.
- Iles S. The loss of early pregnancy. Bailliere's Clin Obstet Gynaecol 1989;3:769-790.
- Oakley A, McPherson A, Reberts H. Miscarriage. London: Fontana; 1984.
- Robinson GE, Stirtzinger R, Stewart DE, et al. Psychological reaction reactions
in women followed for one year after miscarriage. J Reprod Infant Psychol 1994;12:1-36.
- Stirtzinger R, Robinson GE. The psychological effects of spontaneous abortion. Can
Med Assoc J 1989;140:799-805.
- Conway K. Miscarriage. J Psychosom Obstet Gynaecol 1990;12:121-131.
- Yan CM, Mok KM. A survey on the service for patients with miscarriage. HK J Gynaecol
Obstet Midwifery Jul 2002. (in publication)
- Knudsen UB, Hansen V, Juul S, et al. Prognosis of a new pregnancy following previous
spontaneous abortions. European J Obstet Gynaecol Reprod Biol 1991;39:541-545.
- Goldstein SR. Embryonic death in early pregnancy. A new look at the first trimester.
Obstet Gynaecol 1994;84:294-297.
- Bricker L, Farquharson RG. Recurring miscarriage. The Obstetricians and Gynaecologists
2000;2:20-21.
- Quenby S, Farquharson RG. Human chorionic gonadotrophin supplementation in recurring
pregnancy loss: a controlled trial. Fertil Steril 1994;62:708-710.
- Quenby S, Farquharson RG. Recurring miscarriage and endocrine function. In: Farquharson
RG (ed). Vignettes for the MRCOG Volume 2. Salisbury: Quay Publishing; 1999;p89-96.
- Odibo A, Elkousy M, Ural SH, et al. Prevention of preterm birth by cervical clerage
compared with expectant management: a systematic review. Obstet Gynaecol Survey
2003;58:130-136.
- Liddell HS, Pattison NS, Zanderigo A. Recurrent miscarriage-outcome after supportive
care in early pregnancy. Aust N Z J Obstet Gynaecol 1991;31:320-322.
- Yan CM. Pre-conception care in general practice. HK Pract 2002;24:233-238.
- Botto LD, Moore CA, Khoury MJ, et al. Medical progress: neural-tube defects. N Eng
J Med 1999;341:1509-1519.
- Brigham S, Farquharson RG. Pregnancy outcome following idiopathic recurring miscarriage.
In: Farquharson RG (ed). Miscarriage. Salisbury: Quay Publishing; 2002;p152-153.
- Stabile I, Campbell S, Grudinskas JG. Ultrasonic assessment of complications during
first trimester of pregnancy. Lancet 1987;2:1237-1240.
- Pattison NS, Liddell H. Recurrent miscarriage: the Auckland approach to management.
In: Farquharson RG (ed). Miscarriage. Salisbury: Quay publishing; 2002;p91.
|